Entasis Therapeutics Holdings Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$236.2M

256 transactions

Summary

Entasis Therapeutics Holdings Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $234.9MSales: $361K47 insiders

Date	Insider	Type	Value
2022-07-11	Berger Heather A.	D	$61K
2022-07-11	HASTINGS DAVID C	D	$61K
2022-07-11	Mayer Howard	D	$61K
2022-07-11	Meek David D.	D	$61K
2022-07-11	Altarac David(Chief Medical Officer)	J	$0
2022-07-11	Altarac David(Chief Medical Officer)	J	$0
2022-07-11	Altarac David(Chief Medical Officer)	D	—
2022-07-11	Berger Heather A.	J	$0
2022-07-11	Berger Heather A.	J	$0
2022-07-11	HASTINGS DAVID C	J	$0
2022-07-11	HASTINGS DAVID C	J	$0
2022-07-11	Keiley Elizabeth M(General Counsel)	J	$0
2022-07-11	Keiley Elizabeth M(General Counsel)	J	$0
2022-07-11	Keiley Elizabeth M(General Counsel)	D	—
2022-07-11	Mayer Howard	J	$0
2022-07-11	Mayer Howard	J	$0
2022-07-11	Meek David D.	J	$0
2022-07-11	Meek David D.	J	$0
2022-07-11	Mueller John Patrick(Chief Development Officer)	J	$0
2022-07-11	Mueller John Patrick(Chief Development Officer)	J	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Entasis Therapeutics Holdings Inc. — Contributions, Lobbying & Contracts | Poliscope